<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"	
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	xmlns:media="http://search.yahoo.com/mrss/"
	>
<channel>
	<title>Critical Care &#187; The Doctor&#039;s Channel</title>
	<atom:link href="http://www.thedoctorschannel.com/channels/criticalcare/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.thedoctorschannel.com</link>
	<description>Internet TV for Doctors</description>
	<lastBuildDate>Wed, 16 May 2012 23:34:19 +0000</lastBuildDate>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.1.2</generator>
			<item>
		<title>Normal saline not the best surgical replacement fluid: study</title>
		<link>http://www.thedoctorschannel.com/view/normal-saline-not-the-best-surgical-replacement-fluid-study/</link>
		<pubDate>Mon, 16 Apr 2012 22:08:15 +0000</pubDate> 
				<category><![CDATA[Critical Care]]></category>
		<category><![CDATA[Nurses/NP/PA]]></category>
		<category><![CDATA[Reuters Health • The Doctor's Channel Daily Newscast]]></category>
		<category><![CDATA[Surgery]]></category>
		<category><![CDATA[crystalloid]]></category>
		<category><![CDATA[Normal saline]]></category>
		<category><![CDATA[surgery]]></category>
		<guid isPermaLink="false">http://www.thedoctorschannel.com/?p=28223</guid>
		<description><![CDATA[NEW YORK (Reuters Health) – In looking back at more than 30,000 patients who had major open abdominal surgery over a five-year period, researchers found that those who received calcium-free physiologically balanced crystalloid solution for fluid replacement suffered fewer major complications than those who received normal saline. “Patients who received 0.9% saline experienced more complications, -]]></description>
		
			<media:content duration="1:36" medium="video">
		<media:title><![CDATA[Normal saline not the best surgical replacement fluid: study]]></media:title>
	<media:description><![CDATA[NEW YORK (Reuters Health) – In looking back at more than 30,000 patients who had major open abdominal surgery over a five-year period, researchers found that those who received calcium-free physiologically balanced crystalloid solution for fluid replacement suffered fewer major complications than those who received normal saline. “Patients who received 0.9% saline experienced more complications, -]]></media:description>
	<media:player url="http://www.thedoctorschannel.com/view/normal-saline-not-the-best-surgical-replacement-fluid-study/" />
		<media:thumbnail url= "http://www.thedoctorschannel.com/wp-content/uploads/2012/04/Thumbnail_20120416drgd002.jpg"/>
	<media:keywords><![CDATA[crystalloid,Normal saline,surgery]]></media:keywords>
<media:copyright>The Doctor's Channel</media:copyright>
	</media:content>
			</item>
			<item>
		<title>No long-term survival benefit seen with vasopressors in cardiac arrest</title>
		<link>http://www.thedoctorschannel.com/view/no-long-term-survival-benefit-seen-with-vasopressors-in-cardiac-arrest/</link>
		<pubDate>Fri, 30 Mar 2012 21:20:30 +0000</pubDate> 
				<category><![CDATA[Cardiology]]></category>
		<category><![CDATA[Critical Care]]></category>
		<category><![CDATA[Emergency Medicine]]></category>
		<category><![CDATA[Reuters Health • The Doctor's Channel Daily Newscast]]></category>
		<category><![CDATA[cardiac arrest]]></category>
		<category><![CDATA[epinephrine]]></category>
		<category><![CDATA[vasopressin]]></category>
		<category><![CDATA[vasopressors]]></category>
		<guid isPermaLink="false">http://www.thedoctorschannel.com/?p=27556</guid>
		<description><![CDATA[NEW YORK (Reuters Health) – Administration of epinephrine or vasopressin to patients in cardiac arrest improves short-term survival, but has no benefit over the longer term, according to a review reported in Resuscitation online March 15. Furthermore, “There are no alternative vasopressors that provide a long-term survival benefit when compared to epinephrine,” the authors report. -]]></description>
		
			<media:content duration="1:26" medium="video">
		<media:title><![CDATA[No long-term survival benefit seen with vasopressors in cardiac arrest]]></media:title>
	<media:description><![CDATA[NEW YORK (Reuters Health) – Administration of epinephrine or vasopressin to patients in cardiac arrest improves short-term survival, but has no benefit over the longer term, according to a review reported in Resuscitation online March 15. Furthermore, “There are no alternative vasopressors that provide a long-term survival benefit when compared to epinephrine,” the authors report. -]]></media:description>
	<media:player url="http://www.thedoctorschannel.com/view/no-long-term-survival-benefit-seen-with-vasopressors-in-cardiac-arrest/" />
		<media:thumbnail url= "http://www.thedoctorschannel.com/wp-content/uploads/2012/03/Thumbnail_20120330clin001.jpg"/>
	<media:keywords><![CDATA[cardiac arrest,epinephrine,vasopressin,vasopressors]]></media:keywords>
<media:copyright>The Doctor's Channel</media:copyright>
	</media:content>
			</item>
			<item>
		<title>Darbepoietin improves outcomes of severe traumatic brain injury</title>
		<link>http://www.thedoctorschannel.com/view/darbepoietin-improves-outcomes-of-severe-traumatic-brain-injury-2/</link>
		<pubDate>Fri, 23 Mar 2012 14:53:00 +0000</pubDate> 
				<category><![CDATA[Critical Care]]></category>
		<category><![CDATA[Neurology & Neurosurgery]]></category>
		<category><![CDATA[Reuters Health • The Doctor's Channel Daily Newscast]]></category>
		<category><![CDATA[Darbepoietin]]></category>
		<category><![CDATA[TBI]]></category>
		<category><![CDATA[traumatic brain injury]]></category>
		<guid isPermaLink="false">http://www.thedoctorschannel.com/?p=27290</guid>
		<description><![CDATA[NEW YORK (Reuters Health) – Administration of an erythropoiesis-stimulating agent or ESA (in this case, darbepoietin) to patients with severe traumatic brain injury (STBI) improves survival without increasing morbidity, a California team reports in the Archives of Surgery for March. “The current prospective validation of ESA effects in STBI confirms our previous findings,” comment Dr. -]]></description>
		
			<media:content duration="1:31" medium="video">
		<media:title><![CDATA[Darbepoietin improves outcomes of severe traumatic brain injury]]></media:title>
	<media:description><![CDATA[NEW YORK (Reuters Health) – Administration of an erythropoiesis-stimulating agent or ESA (in this case, darbepoietin) to patients with severe traumatic brain injury (STBI) improves survival without increasing morbidity, a California team reports in the Archives of Surgery for March. “The current prospective validation of ESA effects in STBI confirms our previous findings,” comment Dr. -]]></media:description>
	<media:player url="http://www.thedoctorschannel.com/view/darbepoietin-improves-outcomes-of-severe-traumatic-brain-injury-2/" />
		<media:thumbnail url= "http://www.thedoctorschannel.com/wp-content/uploads/2012/03/Thumbnail_20120323clin002.jpg"/>
	<media:keywords><![CDATA[Darbepoietin,TBI,traumatic brain injury]]></media:keywords>
<media:copyright>The Doctor's Channel</media:copyright>
	</media:content>
			</item>
			<item>
		<title>Dexmedetomidine sedation may shorten mechanical ventilation duration</title>
		<link>http://www.thedoctorschannel.com/view/dexmedetomidine-sedation-may-shorten-mechanical-ventilation-duration/</link>
		<pubDate>Thu, 22 Mar 2012 21:36:21 +0000</pubDate> 
				<category><![CDATA[Critical Care]]></category>
		<category><![CDATA[Pharmacists]]></category>
		<category><![CDATA[Reuters Health • The Doctor's Channel Daily Newscast]]></category>
		<category><![CDATA[Dexmedetomidine]]></category>
		<category><![CDATA[midazolam]]></category>
		<category><![CDATA[propofol]]></category>
		<category><![CDATA[sedation]]></category>
		<category><![CDATA[Ventilation]]></category>
		<guid isPermaLink="false">http://www.thedoctorschannel.com/?p=27256</guid>
		<description><![CDATA[NEW YORK (Reuters Health) – Compared with midazolam or propofol for sedation during prolonged mechanical ventilation, dexmedetomidine offers advantages in terms of improved patients’ interaction with ICU staff and shorter time to extubation, according to a report in the Journal of the American Medical Association for March 21. “Accordingly, dexmedetomidine may provide clinically relevant benefits -]]></description>
		
			<media:content duration="1:54" medium="video">
		<media:title><![CDATA[Dexmedetomidine sedation may shorten mechanical ventilation duration]]></media:title>
	<media:description><![CDATA[NEW YORK (Reuters Health) – Compared with midazolam or propofol for sedation during prolonged mechanical ventilation, dexmedetomidine offers advantages in terms of improved patients’ interaction with ICU staff and shorter time to extubation, according to a report in the Journal of the American Medical Association for March 21. “Accordingly, dexmedetomidine may provide clinically relevant benefits -]]></media:description>
	<media:player url="http://www.thedoctorschannel.com/view/dexmedetomidine-sedation-may-shorten-mechanical-ventilation-duration/" />
		<media:thumbnail url= "http://www.thedoctorschannel.com/wp-content/uploads/2012/03/Thumbnail_20120320drgd007.jpg"/>
	<media:keywords><![CDATA[Dexmedetomidine,midazolam,propofol,sedation,Ventilation]]></media:keywords>
<media:copyright>The Doctor's Channel</media:copyright>
	</media:content>
			</item>
			<item>
		<title>Outcomes of STEMI similar with enoxaparin or unfractionated heparin</title>
		<link>http://www.thedoctorschannel.com/view/outcomes-of-stemi-similar-with-enoxaparin-or-unfractionated-heparin/</link>
		<pubDate>Mon, 19 Mar 2012 20:06:31 +0000</pubDate> 
				<category><![CDATA[Cardiology]]></category>
		<category><![CDATA[Cardiology: Interventional]]></category>
		<category><![CDATA[Critical Care]]></category>
		<category><![CDATA[Reuters Health • The Doctor's Channel Daily Newscast]]></category>
		<category><![CDATA[enoxaparin]]></category>
		<category><![CDATA[fibrinolysis]]></category>
		<category><![CDATA[heparin]]></category>
		<category><![CDATA[STEMI]]></category>
		<category><![CDATA[TRANSFER-AMI trial]]></category>
		<guid isPermaLink="false">http://www.thedoctorschannel.com/?p=26896</guid>
		<description><![CDATA[NEW YORK (Reuters Health) – Patients with ST-elevation MI undergoing fibrinolysis followed by immediate or late invasive procedures do just as well with unfractionated heparin (UHF) or with enoxaparin – although enoxaparin is associated with more minor bleeding. Those findings are reported in the American Heart Journal for February by Dr. Shaun G. Goodman, with -]]></description>
		
			<media:content duration="1:59" medium="video">
		<media:title><![CDATA[Outcomes of STEMI similar with enoxaparin or unfractionated heparin]]></media:title>
	<media:description><![CDATA[NEW YORK (Reuters Health) – Patients with ST-elevation MI undergoing fibrinolysis followed by immediate or late invasive procedures do just as well with unfractionated heparin (UHF) or with enoxaparin – although enoxaparin is associated with more minor bleeding. Those findings are reported in the American Heart Journal for February by Dr. Shaun G. Goodman, with -]]></media:description>
	<media:player url="http://www.thedoctorschannel.com/view/outcomes-of-stemi-similar-with-enoxaparin-or-unfractionated-heparin/" />
		<media:thumbnail url= "http://www.thedoctorschannel.com/wp-content/uploads/2012/03/Thumbnail_20120319drgd0041.jpg"/>
	<media:keywords><![CDATA[enoxaparin,fibrinolysis,heparin,STEMI,TRANSFER-AMI trial]]></media:keywords>
<media:copyright>The Doctor's Channel</media:copyright>
	</media:content>
			</item>
			<item>
		<title>High-concentration oxygen therapy for uncomplicated STEMI of little value, study confirms</title>
		<link>http://www.thedoctorschannel.com/view/high-concentration-oxygen-therapy-for-uncomplicated-stemi-of-little-value-study-confirms/</link>
		<pubDate>Fri, 16 Mar 2012 13:39:28 +0000</pubDate> 
				<category><![CDATA[Cardiology]]></category>
		<category><![CDATA[Critical Care]]></category>
		<category><![CDATA[Hospitalist]]></category>
		<category><![CDATA[Reuters Health • The Doctor's Channel Daily Newscast]]></category>
		<category><![CDATA[High-concentration oxygen]]></category>
		<category><![CDATA[myocardial infarction]]></category>
		<category><![CDATA[STEMI]]></category>
		<guid isPermaLink="false">http://www.thedoctorschannel.com/?p=26846</guid>
		<description><![CDATA[NEW YORK (Reuters Health) – Results of a randomized study provide no evidence of benefit from high-concentration oxygen therapy relative to titrated oxygen therapy in patients with initially uncomplicated ST-elevation myocardial infarction (STEMI). “The indoctrinated treatment concept that all patients experiencing a heart attack should receive high-concentration oxygen therapy is not supported by available evidence,” -]]></description>
		
			<media:content duration="1:41" medium="video">
		<media:title><![CDATA[High-concentration oxygen therapy for uncomplicated STEMI of little value, study confirms]]></media:title>
	<media:description><![CDATA[NEW YORK (Reuters Health) – Results of a randomized study provide no evidence of benefit from high-concentration oxygen therapy relative to titrated oxygen therapy in patients with initially uncomplicated ST-elevation myocardial infarction (STEMI). “The indoctrinated treatment concept that all patients experiencing a heart attack should receive high-concentration oxygen therapy is not supported by available evidence,” -]]></media:description>
	<media:player url="http://www.thedoctorschannel.com/view/high-concentration-oxygen-therapy-for-uncomplicated-stemi-of-little-value-study-confirms/" />
		<media:thumbnail url= "http://www.thedoctorschannel.com/wp-content/uploads/2012/03/Thumbnail_20120316drgd009.jpg"/>
	<media:keywords><![CDATA[High-concentration oxygen,myocardial infarction,STEMI]]></media:keywords>
<media:copyright>The Doctor's Channel</media:copyright>
	</media:content>
			</item>
			<item>
		<title>Vasopressin for cardiac arrest does not improve long-term survival</title>
		<link>http://www.thedoctorschannel.com/view/vasopressin-for-cardiac-arrest-does-not-improve-long-term-survival/</link>
		<pubDate>Thu, 15 Mar 2012 19:46:54 +0000</pubDate> 
				<category><![CDATA[Cardiology]]></category>
		<category><![CDATA[Critical Care]]></category>
		<category><![CDATA[Emergency Medicine]]></category>
		<category><![CDATA[Reuters Health • The Doctor's Channel Daily Newscast]]></category>
		<category><![CDATA[adrenaline]]></category>
		<category><![CDATA[cardiac arrest]]></category>
		<category><![CDATA[vasopressin]]></category>
		<guid isPermaLink="false">http://www.thedoctorschannel.com/?p=26821</guid>
		<description><![CDATA[NEW YORK (Reuters Health) – Results of a study conducted in Singapore indicate that vasopressin administered to patients in prolonged cardiac arrest does not improve survival to hospital discharge any more than adrenaline administration &#8212; although vasopressin does appear to improve survival to hospital admission. “Further studies combining vasopressin with hypothermia post-cardiac arrest can be -]]></description>
		
			<media:content duration="1:23" medium="video">
		<media:title><![CDATA[Vasopressin for cardiac arrest does not improve long-term survival]]></media:title>
	<media:description><![CDATA[NEW YORK (Reuters Health) – Results of a study conducted in Singapore indicate that vasopressin administered to patients in prolonged cardiac arrest does not improve survival to hospital discharge any more than adrenaline administration &#8212; although vasopressin does appear to improve survival to hospital admission. “Further studies combining vasopressin with hypothermia post-cardiac arrest can be -]]></media:description>
	<media:player url="http://www.thedoctorschannel.com/view/vasopressin-for-cardiac-arrest-does-not-improve-long-term-survival/" />
		<media:thumbnail url= "http://www.thedoctorschannel.com/wp-content/uploads/2012/03/Thumbnail_20120315drgd006.jpg"/>
	<media:keywords><![CDATA[adrenaline,cardiac arrest,vasopressin]]></media:keywords>
<media:copyright>The Doctor's Channel</media:copyright>
	</media:content>
			</item>
			<item>
		<title>Renin-angiotensin blockade helpful in heart failure with renal disease</title>
		<link>http://www.thedoctorschannel.com/view/renin-angiotensin-blockade-helpful-in-heart-failure-with-renal-disease/</link>
		<pubDate>Fri, 09 Mar 2012 22:59:41 +0000</pubDate> 
				<category><![CDATA[Cardiology]]></category>
		<category><![CDATA[Critical Care]]></category>
		<category><![CDATA[Family Medicine]]></category>
		<category><![CDATA[Hospitalist]]></category>
		<category><![CDATA[Internal Medicine]]></category>
		<category><![CDATA[Nephrology]]></category>
		<category><![CDATA[Nurses/NP/PA]]></category>
		<category><![CDATA[Pharmacists]]></category>
		<category><![CDATA[Reuters Health • The Doctor's Channel Daily Newscast]]></category>
		<category><![CDATA[ACE inhibitor]]></category>
		<category><![CDATA[ARB]]></category>
		<category><![CDATA[chronic kidney disease]]></category>
		<category><![CDATA[CKD]]></category>
		<category><![CDATA[Heart Failure]]></category>
		<category><![CDATA[renin-angiotensin]]></category>
		<guid isPermaLink="false">http://www.thedoctorschannel.com/?p=26379</guid>
		<description><![CDATA[NEW YORK (Reuters Health) – The benefit of renin-angiotensin system inhibition in systolic heart failure (HF) extends to older patients with chronic kidney disease (CKD), a new study suggests. The study found that being prescribed an angiotensin-converting enzyme (ACE) inhibitor or angiotensin receptor blocker (ARB) at hospital discharge was associated with a “significant modest” 14% -]]></description>
		
			<media:content duration="1:43" medium="video">
		<media:title><![CDATA[Renin-angiotensin blockade helpful in heart failure with renal disease]]></media:title>
	<media:description><![CDATA[NEW YORK (Reuters Health) – The benefit of renin-angiotensin system inhibition in systolic heart failure (HF) extends to older patients with chronic kidney disease (CKD), a new study suggests. The study found that being prescribed an angiotensin-converting enzyme (ACE) inhibitor or angiotensin receptor blocker (ARB) at hospital discharge was associated with a “significant modest” 14% -]]></media:description>
	<media:player url="http://www.thedoctorschannel.com/view/renin-angiotensin-blockade-helpful-in-heart-failure-with-renal-disease/" />
		<media:thumbnail url= "http://www.thedoctorschannel.com/wp-content/uploads/2012/03/Thumbnail_20120309clin010.jpg"/>
	<media:keywords><![CDATA[ACE inhibitor,ARB,chronic kidney disease,CKD,Heart Failure,renin-angiotensin]]></media:keywords>
<media:copyright>The Doctor's Channel</media:copyright>
	</media:content>
			</item>
			<item>
		<title>Vena cava filters cut pulmonary embolism fatalities in some categories of patients</title>
		<link>http://www.thedoctorschannel.com/view/vena-cava-filters-cut-pulmonary-embolism-fatalities-in-some-categories-of-patients/</link>
		<pubDate>Tue, 06 Mar 2012 21:43:28 +0000</pubDate> 
				<category><![CDATA[Cardiology]]></category>
		<category><![CDATA[Critical Care]]></category>
		<category><![CDATA[Hospitalist]]></category>
		<category><![CDATA[Internal Medicine]]></category>
		<category><![CDATA[Reuters Health • The Doctor's Channel Daily Newscast]]></category>
		<category><![CDATA[pulmonary embolism]]></category>
		<category><![CDATA[thrombolytic]]></category>
		<category><![CDATA[vena cava filter]]></category>
		<guid isPermaLink="false">http://www.thedoctorschannel.com/?p=26081</guid>
		<description><![CDATA[NEW YORK (Reuters Health) – Data from the National Inpatient Sample indicate that vena cava filters reduce the in-hospital fatality rate among patients with pulmonary embolism who are unstable and in those who are stable and received thrombolytic therapy. “The majority of hospitalized patients with pulmonary embolism, however, were stable and did not receive thrombolytic -]]></description>
		
			<media:content duration="01:44" medium="video">
		<media:title><![CDATA[Vena cava filters cut pulmonary embolism fatalities in some categories of patients]]></media:title>
	<media:description><![CDATA[NEW YORK (Reuters Health) – Data from the National Inpatient Sample indicate that vena cava filters reduce the in-hospital fatality rate among patients with pulmonary embolism who are unstable and in those who are stable and received thrombolytic therapy. “The majority of hospitalized patients with pulmonary embolism, however, were stable and did not receive thrombolytic -]]></media:description>
	<media:player url="http://www.thedoctorschannel.com/view/vena-cava-filters-cut-pulmonary-embolism-fatalities-in-some-categories-of-patients/" />
		<media:thumbnail url= "http://www.thedoctorschannel.com/wp-content/uploads/2012/03/Thumbnail_20120306clin001.jpg"/>
	<media:keywords><![CDATA[pulmonary embolism,thrombolytic,vena cava filter]]></media:keywords>
<media:copyright>The Doctor's Channel</media:copyright>
	</media:content>
			</item>
			<item>
		<title>Amantadine accelerates recovery of cognition after traumatic brain injury</title>
		<link>http://www.thedoctorschannel.com/view/amantadine-accelerates-recovery-of-cognition-after-traumatic-brain-injury/</link>
		<pubDate>Fri, 02 Mar 2012 18:41:49 +0000</pubDate> 
				<category><![CDATA[Critical Care]]></category>
		<category><![CDATA[Hospitalist]]></category>
		<category><![CDATA[Internal Medicine]]></category>
		<category><![CDATA[Neurology & Neurosurgery]]></category>
		<category><![CDATA[Reuters Health • The Doctor's Channel Daily Newscast]]></category>
		<category><![CDATA[amantadine]]></category>
		<category><![CDATA[TBI]]></category>
		<category><![CDATA[traumatic brain injury]]></category>
		<guid isPermaLink="false">http://www.thedoctorschannel.com/?p=26005</guid>
		<description><![CDATA[NEW YORK (Reuters Health) – Patients receiving rehabilitation for prolonged disorders of consciousness after severe traumatic brain injury show an accelerated pace of cognitive recovery when treated with amantadine, a multicenter team reports in the March 1st issue of the New England Journal of Medicine. “Exposure to amantadine is associated with more rapid emergence of -]]></description>
		
			<media:content duration="01:31" medium="video">
		<media:title><![CDATA[Amantadine accelerates recovery of cognition after traumatic brain injury]]></media:title>
	<media:description><![CDATA[NEW YORK (Reuters Health) – Patients receiving rehabilitation for prolonged disorders of consciousness after severe traumatic brain injury show an accelerated pace of cognitive recovery when treated with amantadine, a multicenter team reports in the March 1st issue of the New England Journal of Medicine. “Exposure to amantadine is associated with more rapid emergence of -]]></media:description>
	<media:player url="http://www.thedoctorschannel.com/view/amantadine-accelerates-recovery-of-cognition-after-traumatic-brain-injury/" />
		<media:thumbnail url= "http://www.thedoctorschannel.com/wp-content/uploads/2012/03/Thumbnail_20120229drgd008.jpg"/>
	<media:keywords><![CDATA[amantadine,TBI,traumatic brain injury]]></media:keywords>
<media:copyright>The Doctor's Channel</media:copyright>
	</media:content>
			</item>
	</channel>
</rss>
